What Insife does

Insife is a Danish-based pharmacovigilance (PV) software, technology, and consultancy firm founded in 2017 and headquartered in Søborg, Denmark. The company builds technology to help pharmaceutical companies and regulatory agencies capture, manage, evaluate, and report drug safety data across the full lifecycle of a medicinal product, addressing use cases from adverse drug reaction case processing to signal detection and aggregate reporting.

Insife's product portfolio centers on two platforms: HALOPV, a safety database with multivigilance capabilities that covers end-to-end PV process management and is available in both enterprise-grade and multi-tenant SaaS deployment models; and GRIP (Global Regulatory Intelligence Platform), which combines technology, multi-sourced regulatory intelligence, and a professional networking layer aimed at PV practitioners responsible for identifying and implementing regulatory requirements. Both platforms use automation and AI-driven technologies layered on a multi-tenant SaaS architecture.

The company operates on a B2B enterprise software model, selling HALOPV primarily to pharmaceutical companies (primary segment) and regulatory agencies (secondary segment) via direct enterprise sales, supplemented by consultancy services. In April 2024, Insife was acquired by Qinecsa Solutions, a UK-based specialist in technology-led end-to-end PV services, integrating HALOPV and GRIP alongside Qinecsa's Reportum intake platform and Vigilance Workbench (signal detection) platform. Following the acquisition, Insife operates as a wholly-owned subsidiary within Qinecsa's portfolio, with distribution extended through Qinecsa's global partner network. No public pricing, revenue, or customer logo disclosures are available.

Name

Insife

Legal name

Insife ApS

Website

https://insife.com

Company type

Private

Founded year

2017

Operating status

Acquired

Headcount range

51–100 employees

Short description

Insife is a Danish pharmacovigilance software and consultancy firm that builds the HALOPV safety database and GRIP regulatory intelligence platform for pharmaceutical companies and regulatory agencies managing drug safety across the product lifecycle.

Ownership category

akta.pro rank

Product category

Pharmacovigilance Software

NAICS

Software Publishers (51321)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Pharmacovigilance & Drug Safety Software (HLAGAJAK)

akta.pro secondary industries

PV Regulatory Submissions & Safety Reporting (E2B/CIOMS/Expedited) (HLAGALAJ), Pharmacovigilance Quality & Compliance (PV audits, QPPV support, PSMF) (HLAGAKAH)

Keywords

• Pharmacovigilance software
• Drug safety database
• Regulatory intelligence platform
• Adverse event reporting
• Safety signal detection

Headquarters

HQ city

Søborg

HQ country

Denmark

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Distribution channels1 record

Core offering

Insife develops and delivers pharmacovigilance software platforms and related consultancy for pharmaceutical companies and regulatory agencies. Its core products are HALOPV, a multivigilance safety database covering end-to-end PV process management available as enterprise technology and multi-tenant SaaS, and GRIP, a global regulatory intelligence platform combining technology, multi-sourced intelligence, and networking for PV professionals. The company also provides pharmacovigilance technology consultancy and implementation services to support adoption.

Product overview

Insife is a pharmacovigilance software, technology, and consultancy company that delivers innovation, insights, and solutions to pharmaceutical companies and regulatory agencies worldwide. The company's product portfolio centers on two primary platforms: HALOPV, a safety database with multivigilance capabilities covering end-to-end PV process management available in both enterprise and multi-tenant SaaS formats; and GRIP (Global Regulatory Intelligence Platform), a regulatory intelligence tool combining technology, multi-sourced intelligence, and networking for pharmacovigilance professionals. Following Qinecsa's acquisition of Insife in March 2024, these platforms expanded Qinecsa's pharmacovigilance technology portfolio alongside existing products including Reportum Platform and Vigilance Workbench.

Differentiator

Problem solved

Functional benefit

Brands

• HALOPV: Industry-respected safety database with multivigilance capabilities covering end-to-end management of pharmacovigilance processes. Available as enterprise-grade technology and multi-tenant SaaS offering.
• GRIP

Products and services

• HALOPV Platform Industry-respected pharmacovigilance safety database with multivigilance capabilities covering end-to-end management of PV processes. Available as enterprise-grade technology deployment and as a multi-tenant SaaS offering for cost-effective use. Used by pharmaceutical companies and regulatory agencies for drug safety data capture, adverse event management, and signal evaluation across the drug lifecycle.
• GRIP (Global Regulatory Intelligence Platform) Global regulatory intelligence platform that combines technology, multi-sourced intelligence, and networking for pharmacovigilance professionals involved in identifying, assessing, and implementing regulatory requirements across global PV obligations. Designed for use by pharmaceutical PV teams and regulatory agencies.
• Pharmacovigilance Technology and Consultancy Services Insife delivers pharmacovigilance technology and consultancy services to pharmaceutical companies and regulatory agencies worldwide, supporting adoption of the HALOPV and GRIP platforms and providing technology-enabled expertise on safety data management and regulatory compliance.

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

One partnership is on record.

• Qinecsa SolutionscoreStrategic or Co-development Partner · 1 April 2024Qinecsa Solutions acquired Insife ApS in April 2024 as a strategic move to strengthen Qinecsa's position as a leading provider of pharmacovigilance solutions. The acquisition brings together Qinecsa's Reportum and QVW platforms with Insife's HALOPV and GRIP platforms, creating an enhanced suite of pharmacovigilance services. Martin Holm-Petersen, CEO of Insife, noted the acquisition enables expansion of global footprint and underlines Insife's position as the number one technology provider for pharmacovigilance.

Recent moves5 records

Expansion highlights2 records

Broad incumbents

• PharmaLex (Cencora): PharmaLex, now part of Cencora/World Courier, provides pharmacovigilance services and technology-enabled solutions. It is comparable to Insife in the PV services-plus-technology model and competes for outsourced and technology-supported PV engagements.
• Veeva Systems (Vault Safety): Veeva's Vault Safety is a major cloud-native pharmacovigilance platform used by mid-to-large pharma. It competes with HALOPV in safety case management and benefits from Veeva's broader Vault clinical and regulatory suite, making it a key alternative for prospective Insife customers.
• United BioSource (UBC): UBC, a subsidiary of Express Scripts, provides pharmacovigilance and drug safety services along with technology solutions. It competes with Insife's consultancy and software offerings for pharma customers seeking outsourced and tech-enabled PV support.
• Qinecsa Solutions: Qinecsa Solutions is Insife's parent company and the acquirer of HALOPV and GRIP. Its Reportum and Vigilance Workbench platforms overlap with Insife's offerings, and the combined entity now represents the broader competitive context for Insife's products.
• Oracle (Argus Safety): Oracle's Argus Safety is the dominant enterprise pharmacovigilance safety database platform, serving large pharma with a broad regulatory and clinical software suite. It competes directly with Insife's HALOPV in the safety database category but as part of a much larger enterprise software portfolio.

Direct peers

• ArisGlobal: ArisGlobal offers LifeSphere Safety, a competing pharmacovigilance platform covering case management, signal detection, and regulatory reporting. It is one of the closest direct peers to Insife in the PV software market, with similar mid-market and enterprise positioning.
• EXTEDO: EXTEDO provides regulatory information management and pharmacovigilance software solutions to life sciences companies. It overlaps with both HALOPV (safety) and GRIP (regulatory intelligence), serving a similar pharma customer base across Europe and globally.
• Ennov: Ennov offers a unified regulatory and pharmacovigilance platform (Ennov Pharmacovigilance) targeting mid-sized life sciences companies. It is a direct competitor in the PV software space with comparable end-to-end case management and SaaS deployment options.

Emerging players

• Sarjen Systems: Sarjen Systems offers pharmacovigilance software solutions with a focus on adverse event case management. As a smaller, more specialized PV software vendor, it competes with HALOPV in a similar niche of the safety database market.
• MaxApplication: MaxApplication provides pharmacovigilance and drug safety software solutions, including safety database and case management capabilities. It is a comparable smaller-scale PV software vendor addressing similar pharma customer needs as Insife.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/insife
• LinkedInlinkedin.com/company/insife

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Insife